(Q51775361)

12 April 2018

title

Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation. (English)

1 reference

12 April 2018

author name string

Jocken JW

1

1 reference

12 April 2018

Blaak EE

2

1 reference

12 April 2018

Schiffelers S

3

1 reference

12 April 2018

Arner P

4

1 reference

12 April 2018

van Baak MA

5

1 reference

12 April 2018

Saris WH

6

1 reference

12 April 2018

language of work or name

English

0 references

publication date

28 November 2006

1 reference

12 April 2018

International Journal of Obesity

published in

1 reference

12 April 2018

volume

31

1 reference

12 April 2018

issue

5

1 reference

12 April 2018

page(s)

813-819

1 reference

12 April 2018

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803499

exact match

0 references

cites work

Pharmacogenetics of beta-1- and beta-2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Beta2-adrenoceptor polymorphisms: relation between in vitro and in vivo phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Beta2-adrenoceptor gene polymorphism, body weight, and physical activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

beta2-adrenergic receptor polymorphisms and salbutamol-stimulated energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Association of a human G-protein beta3 subunit variant with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNB3) C825T polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

The gross composition of the body

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

A comparison of linkage disequilibrium measures for fine-scale mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Fatty acid kinetic responses to exercise. Effects of obesity, body fat distribution, and energy-restricted diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Gender differences in fat metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Impaired beta-adrenergically mediated lipolysis in skeletal muscle of obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

The Gly16-->Arg16 and Gln27-->Glu27 polymorphisms of beta2-adrenergic receptor are associated with metabolic syndrome in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

A circadian rhythm in lipid mobilization which is altered in IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

The Gln27Glu beta2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Interactions among the α2-, β2-, and β3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Impact of polymorphisms of the human β 2 -adrenoceptor gene on obesity in a French population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

beta-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

G-Protein β3 Subunit Gene ( GNB3 ) Variant in Causation of Essential Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

Relationship between β-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

Catecholamine-induced lipolysis in obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803499

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0803499

1 reference

12 April 2018

1 reference

12 April 2018